Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share

v3.22.2
Earnings Per Share
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Share
6.
Earnings Per Share

The following table presents computations of basic and diluted loss per share:

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Cinemark Holdings, Inc.

 

$

(73.4

)

 

$

(142.4

)

 

$

(147.4

)

 

$

(350.7

)

Loss allocated to participating share-based awards (1)

 

 

1.4

 

 

 

2.7

 

 

 

2.5

 

 

 

5.9

 

Net loss attributable to common stockholders

 

$

(72.0

)

 

$

(139.7

)

 

$

(144.9

)

 

$

(344.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

118.2

 

 

 

117.2

 

 

 

118.0

 

 

 

117.2

 

Common equivalent shares for restricted stock units (2)

 

 

 

 

 

 

 

 

 

 

 

 

Common equivalent shares for convertible notes and warrants (3)

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

 

 

118.2

 

 

 

117.2

 

 

 

118.0

 

 

 

117.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per share attributable to common stockholders

 

$

(0.61

)

 

$

(1.19

)

 

$

(1.23

)

 

$

(2.94

)

Diluted loss per share attributable to common stockholders

 

$

(0.61

)

 

$

(1.19

)

 

$

(1.23

)

 

$

(2.94

)

(1)
For the three months ended June 30, 2022 and 2021, a weighted average of approximately 2.27 shares and 2.28 shares of restricted stock, respectively, were considered participating securities. For the six months ended June 30, 2022 and 2021, a weighted average of approximately 2.03 shares and 1.99 shares of restricted stock, respectively, were considered participating securities.
(2)
For the three months ended June 30, 2022 and 2021, approximately 0.25 and 0.16 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. For the six months ended June 30, 2022 and 2021, approximately 0.28 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive.
(3)
For the three and six months ended June 30, 2022 and 2021, diluted earnings (loss) per share excludes the conversion of the 4.50% Convertible Senior Notes into 32.0 shares of common stock, as well as outstanding warrants, as they would be anti-dilutive. See further discussion below.

Share-based awards

The Company considers its unvested share-based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of loss per share pursuant to the two-class method. Basic loss per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net loss by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted loss per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method.

Convertible notes, hedges and warrants

The 4.50% Convertible Senior Notes, discussed further in Note 13 of the Company’s Annual Report on Form 10-K filed February 26, 2021, may be considered dilutive in future periods in which the Company has net income. The impact of such dilution on earnings per share will be calculated under the if-converted method, which requires that all of the shares of the Company’s common stock issuable upon conversion of the 4.50% Convertible Senior Notes will be included in the calculation of diluted EPS assuming conversion at the beginning of the reporting period. The closing price of the Company's common stock did not exceed the strike price of $18.65 per share (130% of the initial exercise price of $14.35 per share) during at least 20 of the last 30 trading days of the six months ended June 30, 2022 and, therefore, the 4.50% Convertible Senior Notes are not convertible during the third quarter of 2022. The if-converted value of the 4.50% Convertible Senior Notes exceeded the aggregate outstanding principal value of the notes by $58.4 as of June 30, 2022.

The Company entered into hedge transactions with counterparties in connection with the issuance of the 4.50% Convertible Senior Notes. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to 4.50% Convertible Senior Notes, the number of shares of the Company’s common stock underlying the 4.50% Convertible Notes, which initially gives the Company the option to purchase approximately 32.0 shares of the Company’s common stock at a price of approximately $14.35 per share. Concurrently with entering into the convertible note hedge transactions, the Company also entered into warrant transactions with each option counterparty whereby the Company sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, up to the same number of shares of the Company’s common stock, which initially gives the option counterparties the option to purchase approximately 32.0 million shares at a price of approximately $22.08 per share. The

economic effect of these transactions is to effectively raise the strike price of the 4.50% Convertible Senior Notes from approximately $18.65 per share of the Company’s common stock to approximately $22.08 per share.